Thursday, February 24, 2022 11:35:55 PM
Mav,
If we knew that the BLA was submitted, whether to one regulator, or all four, we ought to be trading even higher than if we had the Journal. We'd know with reasonable certainty that in six months or less we'd have an approval. I suspect that it's possible that they'd do it before announcing it, but the BLA's the biggest thing they're doing, nothing is bigger than approvals from the regulators.
I don't know if the company has made a submittal, but if not, we've got to be getting close. It is one thing that they can do without the Journal, TLD, etc. and it's something they've been working on for well over a year. I don't know that they may not be waiting to qualify the FlaskWorks unit first, but if they aren't waiting, it's very possible that the BLA has been filed with at least one of the regulators, and perhaps all four.
Gary
If we knew that the BLA was submitted, whether to one regulator, or all four, we ought to be trading even higher than if we had the Journal. We'd know with reasonable certainty that in six months or less we'd have an approval. I suspect that it's possible that they'd do it before announcing it, but the BLA's the biggest thing they're doing, nothing is bigger than approvals from the regulators.
I don't know if the company has made a submittal, but if not, we've got to be getting close. It is one thing that they can do without the Journal, TLD, etc. and it's something they've been working on for well over a year. I don't know that they may not be waiting to qualify the FlaskWorks unit first, but if they aren't waiting, it's very possible that the BLA has been filed with at least one of the regulators, and perhaps all four.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
